Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Temferon, a hematopoietic stem cell gene therapy, for metastatic renal cell carcinoma (clear cell RCC)…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas [Phase 1]
Phase 1 study evaluating CD45RA+ depleted haploidentical stem cell transplantation in children with relapsed or refractory solid tumors and …
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-2 with radiotherapy and pembrolizumab in patients refractory to checkpoint blockade; results have bee…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma [Phase 1, Phase 2]
A Phase I/II trial evaluating the safety and preliminary efficacy of vaccinations with allogeneic dendritic cells fused with autologous tumo…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma
This completed study reports real-world evidence on using tivozanib as first-line therapy for metastatic clear cell renal cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery [EARLY_Phase 1]
An early-phase trial evaluating nivolumab with or without bevacizumab or ipilimumab before surgery in patients with resectable metastatic re…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma [NA]
This entry notes a post-marketing surveillance study of PROSENSE cryotherapy for renal cell carcinoma, with the study status ACTIVE_NOT_RECR…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Navigated Partial Nephrectomy [NA]
This entry notes the completion of a clinical trial evaluating navigated partial nephrectomy for renal cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer [Phase 2]
Phase 2 trial evaluating stereotactic ablative body radiation therapy for patients with primary renal cell carcinoma. The current status is …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Advantage of a Fast-recovery Protocol for Minimally Invasive Kidney Surgery
A clinical trial update notes completion of a study evaluating a fast-recovery protocol for minimally invasive kidney surgery in renal cell …
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Metastatic Renal Cell Carcinoma [NA]
A terminated clinical trial evaluating non-contrast arterial spin-labeled MRI to assess therapy response in metastatic renal cell carcinoma;…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors [Phase 3]
Phase 3 trial evaluating the duration of PD-1/PD-L1 inhibitor therapy in advanced solid tumors; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT [Phase 2]
A Phase 2 multicenter randomized trial evaluating finerenone and empagliflozin to delay renal function decline after radical nephrectomy in …
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer [Phase 1]
Phase 1 study of aldesleukin in combination with pembrolizumab in advanced or metastatic renal cell carcinoma has been terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma
This clinical trial update reports on a study evaluating the abscopal effect of ultra-hypofractionated radiation plus immunotherapy in metas…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
This completed clinical trial evaluates the feasibility of a smartphone app for patients with advanced renal cell carcinoma undergoing combi…
-
CLINICAL_TRIALS trial_result · 2025-12-04Clinical Trial Update: The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer
A completed clinical trial update assessing the pharmacokinetic variability of sunitinib in patients with metastatic renal cancer.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma [Phase 2]
A Phase II trial of nivolumab plus ipilimumab in patients with Renal Medullary Carcinoma has been terminated, with the study status updated.
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy [NA]
The clinical trial evaluating the HistoSonics Investigational System for histotripsy treatment of primary solid renal tumors has completed w…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
An observational study evaluating the efficacy and safety of the Avelumab + Axitinib combination in participants with advanced renal cell ca…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer [Phase 3]
This Phase 3 trial compares toripalimab plus axitinib against sunitinib monotherapy in unresectable or metastatic renal cell carcinoma; the …
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Comparing Two Different Approaches in Robotic-Assisted Renal Surgery [NA]
A completed clinical trial comparing two robotic-assisted approaches for renal tumor surgery.
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.